140 related articles for article (PubMed ID: 2064356)
1. Induction of immunopotentiation activity by a protein-bound polysaccharide, PSK (review).
Sakagami H; Aoki T; Simpson A; Tanuma S
Anticancer Res; 1991; 11(2):993-9. PubMed ID: 2064356
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of human peripheral blood polymorphonuclear cell iodination by PSK subfractions.
Sakagami H; Kim F; Konno K
Anticancer Res; 1990; 10(3):697-702. PubMed ID: 2369086
[TBL] [Abstract][Full Text] [Related]
3. Functional maturation of monocytes/macrophages induced by PSK subfractions.
Kurakata Y; Sakagami H; Sato A; Kikuchi K; Takeda M; Asano K; Sato T
Anticancer Res; 1991; 11(5):1767-72. PubMed ID: 1768050
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of interferon-gamma-induced human myelogenous leukemic cell differentiation by high molecular weight PSK subfraction.
Kim F; Sakagami H; Tanuma S; Konno K
Anticancer Res; 1990; 10(1):55-8. PubMed ID: 2110432
[TBL] [Abstract][Full Text] [Related]
5. PSK and OK-432-induced immunomodulation of inducible nitric oxide (NO) synthase gene expression in mouse peritoneal polymorphonuclear leukocytes and NO-mediated cytotoxicity.
Asai K; Kato H; Hirose K; Akaogi K; Kimura S; Mukai S; Inoue M; Yamamura Y; Sano H; Sugino S; Yoshikawa T; Kondo M
Immunopharmacol Immunotoxicol; 2000 May; 22(2):221-35. PubMed ID: 10952028
[TBL] [Abstract][Full Text] [Related]
6. PSK, a polysaccharide from Coriolus vesicolor, enhances oxygen metabolism of murine peritoneal macrophages and the host resistance to listerial infection.
Saito H; Tomioka H; Sato K
J Gen Microbiol; 1988 Apr; 134(4):1029-35. PubMed ID: 3141579
[TBL] [Abstract][Full Text] [Related]
7. Effect of immunostimulants and antitumor agents on tumor necrosis factor (TNF) production.
Mori H; Mihara M; Teshima K; Uesugi U; Xu Q; Sakamoto O; Koda A
Int J Immunopharmacol; 1987; 9(8):881-92. PubMed ID: 2448255
[TBL] [Abstract][Full Text] [Related]
8. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
Fisher M; Yang LX
Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
[TBL] [Abstract][Full Text] [Related]
9. The augmentative effect of a protein-bound polysaccharide (PSK) on tumoricidal activity of the soluble factor produced by a streptococcal preparation (OK-432)-activated macrophages.
Baba N; Kawami H; Sato Y; Takayama T; Toge T
Biotherapy; 1991; 3(4):359-64. PubMed ID: 1786200
[TBL] [Abstract][Full Text] [Related]
10. [Induction of manganese superoxide dismutase by an immunopotentiator as a mechanism of inhibiting of malignant progression of murine tumor cells].
Habelhah H
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):519-29. PubMed ID: 9846281
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of tumor necrosis factor-induced human myelogenous leukemic cell differentiation by high molecular weight PSK subfraction.
Sakagami H; Ikeda M; Konno K
Biochem Biophys Res Commun; 1989 Jul; 162(2):597-603. PubMed ID: 2757633
[TBL] [Abstract][Full Text] [Related]
12. Effect of PSK and its subfractions on peripheral blood lymphocytes mediated cytotoxicity against urinary bladder tumor cells.
Mizutani Y; Nio Y; Yoshida O
J Urol; 1992 Nov; 148(5):1571-6. PubMed ID: 1433570
[TBL] [Abstract][Full Text] [Related]
13. The protective activity of immunostimulants against Listeria monocytogenes infection in mice.
Tomioka H; Sato K; Saito H
J Med Microbiol; 1992 Feb; 36(2):112-6. PubMed ID: 1740781
[TBL] [Abstract][Full Text] [Related]
14. [Restoration of depressed immune responses by PSK in C3H/He mice bearing the syngeneic X5563 tumor].
Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3453-60. PubMed ID: 3789756
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.
Matsunaga K; Iijima H; Aota M; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
J Clin Lab Immunol; 1992 Jan; 37(1):21-37. PubMed ID: 1339233
[TBL] [Abstract][Full Text] [Related]
16. [Effect of a protein-bound polysaccharide, PSK, on human hemopoietic progenitors].
Tsuji K; Takagi M; Kobayashi T; Ishiguro A; Naganuma K; Koike K; Nakahata T; Akabane T
Nihon Ketsueki Gakkai Zasshi; 1989 May; 52(3):594-600. PubMed ID: 2618537
[TBL] [Abstract][Full Text] [Related]
17. [A suppressive effect of PSK, a protein-bound polysaccharide preparation, on tumor growth: a new effect of PSK on cell motility].
Katano M; Yamamoto H; Torisu M
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2321-6. PubMed ID: 3606151
[TBL] [Abstract][Full Text] [Related]
18. Induction of gene expression for nitric oxide synthase by immunomodulating drugs in the RAW264.7 murine macrophage cell line.
Asai K; Kato H; Kimura S; Mukai S; Kawahito Y; Sano H; Kondo M; Akaogi K; Hirose K
Cancer Immunol Immunother; 1996 Jun; 42(5):275-9. PubMed ID: 8706048
[TBL] [Abstract][Full Text] [Related]
19. Morphological and biochemical alterations of macrophages produced by a glycan, PSK.
Kamisato JK; Nowakowski M
Immunopharmacology; 1988; 16(2):89-96. PubMed ID: 3204014
[TBL] [Abstract][Full Text] [Related]
20. The TLR2 agonist in polysaccharide-K is a structurally distinct lipid which acts synergistically with the protein-bound β-glucan.
Quayle K; Coy C; Standish L; Lu H
J Nat Med; 2015 Apr; 69(2):198-208. PubMed ID: 25510899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
